2023
DOI: 10.1007/s00432-023-05089-z
|View full text |Cite
|
Sign up to set email alerts
|

Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 48 publications
0
1
0
Order By: Relevance
“…Elevated TK1 levels can be detected in both hematologic malignancies and solid tumors 16 . TK1 has been proved to be a new biomarker in several cancers, including hepatocellular carcinoma 17 , prostate cancer 18 , melanoma 19 , and breast cancer 20 et al In addition, TK1 combined with HE4 and CA125 showed a better diagnostic performance in ovarian cancer 21 , 22 . Serum TK1 can act as a novel biomarker in patients with HR(+)/HER2(−) advanced breast cancer 23 .…”
Section: Discussionmentioning
confidence: 99%
“…Elevated TK1 levels can be detected in both hematologic malignancies and solid tumors 16 . TK1 has been proved to be a new biomarker in several cancers, including hepatocellular carcinoma 17 , prostate cancer 18 , melanoma 19 , and breast cancer 20 et al In addition, TK1 combined with HE4 and CA125 showed a better diagnostic performance in ovarian cancer 21 , 22 . Serum TK1 can act as a novel biomarker in patients with HR(+)/HER2(−) advanced breast cancer 23 .…”
Section: Discussionmentioning
confidence: 99%